134 related articles for article (PubMed ID: 26254278)
1. Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
Berardi R; Brunelli A; Pagliaretta S; Paolucci V; Conti A; Goteri G; Refai M; Pompili C; Marcantognini G; Morgese F; Ballatore Z; Savini A; De Lisa M; Caramanti M; Santoni M; Zizzi A; Piva F; Mazzanti P; Onofri A; Sabbatini A; Scarpelli M; Cascinu S
Oncotarget; 2015 Aug; 6(22):19305-15. PubMed ID: 26254278
[TBL] [Abstract][Full Text] [Related]
2. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
[TBL] [Abstract][Full Text] [Related]
3. The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions.
Berardi R; Goteri G; Pagliaretta S; Paolucci V; Morgese F; Conti A; Refai M; Pompili C; Duranti C; Marcantognini G; Savini A; Caramanti M; Rinaldi S; Torniai M; Santoni M; Zizzi A; Mazzanti P; Onofri A; Ricci G; Scarpelli M
J Thorac Dis; 2020 Dec; 12(12):7245-7256. PubMed ID: 33447413
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
5. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.
Hashimoto A; Tarner IH; Bohle RM; Gaumann A; Manetti M; Distler O; Steinmeyer J; Ulfgren AK; Schulz A; Gay S; Müller-Ladner U; Neumann E
Arthritis Rheum; 2007 Apr; 56(4):1094-105. PubMed ID: 17393418
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
Kang BW; Kim JG; Chae YS; Bae HI; Kwon O; Chung HY; Yu W; Song HS; Kang YN; Ryu SW; Lee KH; Bae YK; Choi JH; Kim SW; Ryoo HM; Cho CH; Chae HD; Park KW; Gu MJ; Bae BJ
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e40-5. PubMed ID: 23551429
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib efficacy in thymic carcinomas seems not to require c-KIT or PDGFR-alpha mutations.
Pagano M; Sierra NM; Panebianco M; Rossi G; Gnoni R; Bisagni G; Boni C
Anticancer Res; 2014 Sep; 34(9):5105-10. PubMed ID: 25202099
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic predictors of survival in patients with thymic tumors.
Lequaglie C; Giudice G; Brega Massone PP; Conti B; Cataldo I
J Cardiovasc Surg (Torino); 2002 Apr; 43(2):269-74. PubMed ID: 11887069
[TBL] [Abstract][Full Text] [Related]
9. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
11. Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors.
Monica V; Familiari U; Chiusa L; Rossi G; Novero D; Busso S; Ruffini E; Ardissone F; Scagliotti GV; Papotti M
Lung Cancer; 2013 Mar; 79(3):228-35. PubMed ID: 23276504
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
15. Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.
Pallaud C; Reck M; Juhasz E; Szima B; Yu CJ; Burdaeva O; Orlov S; Hilton M; Archer V; Mok T
Lung Cancer; 2014 Oct; 86(1):67-72. PubMed ID: 25154982
[TBL] [Abstract][Full Text] [Related]
16. PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.
Estevez-Garcia P; Castaño A; Martin AC; Lopez-Rios F; Iglesias J; Muñoz-Galván S; Lopez-Calderero I; Molina-Pinelo S; Pastor MD; Carnero A; Paz-Ares L; Garcia-Carbonero R
BMC Cancer; 2012 Nov; 12():514. PubMed ID: 23146028
[TBL] [Abstract][Full Text] [Related]
17. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?
Viti A; Bertolaccini L; Terzi A
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1054-8. PubMed ID: 25193970
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.
Allegrini G; Coltelli L; Orlandi P; Fontana A; Camerini A; Ferro A; Cazzaniga M; Casadei V; Lucchesi S; Bona E; Di Lieto M; Pazzagli I; Villa F; Amoroso D; Scalese M; Arrighi G; Molinaro S; Fioravanti A; Finale C; Triolo R; Di Desidero T; Donati S; Marcucci L; Goletti O; Del Re M; Salvadori B; Ferrarini I; Danesi R; Falcone A; Bocci G
Pharmacogenomics; 2014 Dec; 15(16):1985-99. PubMed ID: 25521357
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
[TBL] [Abstract][Full Text] [Related]
20. HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array.
Tuomisto TT; Rissanen TT; Vajanto I; Korkeela A; Rutanen J; Ylä-Herttuala S
Atherosclerosis; 2004 May; 174(1):111-20. PubMed ID: 15135259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
